Literature DB >> 10704707

Evaluation of telomerase activity in bronchial lavage as a potential diagnostic marker for malignant lung disease.

G Xinarianos1, F M Scott, T Liloglou, W Prime, L Turnbull, M Walshaw, J K Field.   

Abstract

Telomerase is a ribonucleoprotein DNA polymerase that maintains the telomeric region of chromosomes lost during successive rounds of cell division. We used the telomeric repeat amplification protocol (TRAP) assay to examine telomerase activity in bronchial lavage (BL) samples from individuals undergoing diagnosis of lung cancer. Telomerase activity was detected in 17 (47%) of 36 samples examined. In particular, 16 (70%) of 23 BL specimens obtained from lung cancer patients showed detectable telomerase activity, while only 1 of 13 (8%) specimens obtained from patients without lung cancer demonstrated activity (P=0.00038). Moreover, 9 (90%) of 10 BL specimens, which were cytologically positive for lung cancer, were also positive for telomerase activity, while 7 (54%) of 13 cytologically negative BL specimens for lung cancer showed detectable telomerase activity. Detection of telomerase activity combined with cytology were able to identify 17 (74%) of 23 lung cancer cases whereas cytology alone identified 10 (43%) of 23 such cases (P=0.035). Our findings indicate that telomerase is a specific marker for malignant lung disease and a potential complementary tool to cytology in the diagnosis of certain lung cancer cases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10704707     DOI: 10.1016/s0169-5002(99)00111-7

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  4 in total

Review 1.  Lung cancer. 9: Molecular biology of lung cancer: clinical implications.

Authors:  K M Fong; Y Sekido; A F Gazdar; J D Minna
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

2.  Detection of lung cancer using MAGE A1-6 and SSX4 RT-PCR expression profiles in the bronchial wash fluid.

Authors:  Kwan-Ho Lee; Kyung-Chul Shin; Chae-Hun Lee; Sang-Hoon Jheon; Chang-Ho Jeon
Journal:  Cancer Res Treat       Date:  2007-06-30       Impact factor: 4.679

3.  Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours.

Authors:  S Lantuejoul; J C Soria; D Moro-Sibilot; L Morat; S Veyrenc; P Lorimier; P Y Brichon; L Sabatier; C Brambilla; E Brambilla
Journal:  Br J Cancer       Date:  2004-03-22       Impact factor: 7.640

4.  Telomerase activity in non-small cell lung cancer.

Authors:  Katarzyna Dobija-Kubica; Marzena Zalewska-Ziob; Krzysztof Bruliński; Paweł Rogoziński; Andrzej Wiczkowski; Agata Gawrychowska; Jacek Gawrychowski
Journal:  Kardiochir Torakochirurgia Pol       Date:  2016-03-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.